Wednesday, 24 May 2017

India News

  • Cipla to build biotech facility in South Africa

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Indian drug major Cipla, recently announced that its South African subsidiary will invest R1.3 billion into the country's first biotech manufacturing facility, for the production...Read more

  • Dr Appaji: Pharmexcil is taking Indian Pharma to new heights

    India |  Influencers | By Vipul Murarka | 0 Comment

    The Pharmaceutical Export Promotion Council of India (PHARMEXCIL), set up by the Ministry of Commerce and Industry, Government of India, has been tasked with the promotion of the Indian pha...Read more

  • Hetreo launches biosimilar for colorectal cancer

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Indian drug major Hetero recently announced the launch of biosimilar of 'Bevacizumab', used in treating metastatic colorectal cancer (mCRC), under the brand name 'CizumabTM'. Hyd...Read more

  • Cipla keeps the flag high for affordable drugs

    India |  Analysis | By Amrita Tejasvi | 0 Comment

    Cipla, which is known for providing affordable drugs to cancer and HIV patients in developing countries, clocked a growth of 17 percent in the year ending 2012. The domestic turnover incr...Read more

  • Phenomenex extends Lux Chiral Bulk Media Line

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore:A global leader in advanced technologies for separation sciences, Phenomenex has announced the extension of its successful Lux chiral bulk media line to meet the needs of preparat...Read more

  • Activists challenge Gilead to give up Hep C drug patent

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Initiative for Medicines, Access & Knowledge (I-MAK), a team of lawyers and scientists campaigning for global accessibility of medicines for hepatitis C and HIV patients, has...Read more

  • Teva, Sun to pay $2.15 bn to Pfizer, Takeda to settle patent suit

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Teva Pharmaceuticals Industries, Israel, and Sun Pharmaceutical Industries, India, are going to pay a combined amount of $2.15 billion to US-based Pfizer in order to settle a pat...Read more

  • Adcock-Ingram buys Cosme Farma India for $86 mn

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Adcock-Ingram, which is one of the biggest pharma companies of South Africa, paid a huge premium to buy out Indian firm, Cosme Farma, in an attempt to gain more access to markets...Read more

  • Samantha Su, Simranjit Singh: Finding skilled professionals is a challenge in Singapore

    India |  Opinion | By BioSpectrum Bureau | 0 Comment

    In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Theoretically, the synergy created between them spurs the company to bu...Read more

  • Venus bags additional US patent for Vancoplus

    India |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: India's Chandigarh based Venus Remedies has bagged an additional patent for Vancoplus from USPTO. Vancoplus is an antibiotic adjuvant entity, effective against the deadly resista...Read more

  • Aortic stent grafts market to grow at slow pace'

    India |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: The global aortic stent grafts market will increase in value from an estimated $1.2 billion in 2013 to just over $1.9 billion by 2020, representing a compound annual growth rate ...Read more

  • Ghana to probe import of Indian anti-malarial drug

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Ghana's Health Ministry has set up a three-member Ministerial Committee to investigate the import of an anti-malarial medicine for children from India. The Country's Food and Dr...Read more

  • IIM-B, C-CAMP partner to support entrepreneurs in life sciences

    India |  News | By Vipul Murarka | 0 Comment

    Bangalore: On September 1, 2012, IIM Bangalore and C-CAMP signed an MoU to set up of incubation centers at the C-CAMP and at NS Raghavan Centre for Entrepreneurial Learning at IIM Bangalore...Read more

  • Kemwell CMD: Retaining staff is biggest challenge

    India |  Influencers | By BioSpectrum Bureau | 0 Comment

    Kemwell Biopharma, which headquartered in Bangalore, is one-of-India's largest contract manufacturers of pharmaceuticals with over 30 years of experience. The company develops and manufactu...Read more

  • Novartis to sell Themis diclofenac topical gel

    India |  News | By BioSpectrum Bureau | 0 Comment

    Mumbai: Themis Medicare, which is a partner firm of Australian drug delivery technology company Phosphagenics, entered into a license and supply agreement with Novartis India to sell its Th...Read more

  • Medical Tourism: Asia's top destinations

    India |  Analysis | By Aishwarya Venkatesh | 0 Comment

    Singapore:  Asia is a special destination for those looking for quality healthcare at low cost. BioSpectrum takes a look at some of the hottest destinations that are attracting patients fr...Read more

  • EU suspends GVK Bio medicine for non-compliance

    India |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: European Medicines Agency has slammed Indian contract research organization, GVK BioScience, for non-compliance with good clinical practice at its Hyderabad site. Meanwhile, the ...Read more

  • Pricing revision to cost Indian pharma $160 mn

    India |  Analysis | By BioSpectrum Bureau | 0 Comment

    Mumbai: The pharmaceutical industry will be widely impacted after India's National Pharmaceutical Pricing Authority (NPPA) notified leading drug majors about ceiling prices. This will lead ...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls